Cart
sales@molnova.com
Acetohydroxamic acid
CAS No. 546-88-3
Acetohydroxamic acid( AHA | NSC 5073 | NSC 176136 | NSC 408425 )
Catalog No. M14966 CAS No. 546-88-3
Acetohydroxamic Acid, a synthetic drug derived from hydroxylamine and ethyl acetate, is similar in structure to urea.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 43 | In Stock |
|
| 500MG | 81 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAcetohydroxamic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionAcetohydroxamic Acid, a synthetic drug derived from hydroxylamine and ethyl acetate, is similar in structure to urea.
-
DescriptionAcetohydroxamic Acid, a synthetic drug derived from hydroxylamine and ethyl acetate, is similar in structure to urea. In the urine, it acts as an antagonist of the bacterial enzyme urease. Acetohydroxamic Acid has no direct antimicrobial action and does not acidify urine directly. It is used, in addition to antibiotics or medical procedures, to treat chronic urea-splitting urinary infections.
-
In Vitro——
-
In Vivo——
-
SynonymsAHA | NSC 5073 | NSC 176136 | NSC 408425
-
PathwayMetabolic Enzyme/Protease
-
TargetMMP
-
RecptorMMP
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number546-88-3
-
Formula Weight75.07
-
Molecular FormulaC2H5NO2
-
Purity>98% (HPLC)
-
SolubilitySoluble in Water
-
SMILESCC(NO)=O
-
Chemical NameAcetamide, N-hydroxy- (9CI)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Palinska KA, et al. Microbiology. 2000 Dec;146 Pt 12:3099-107.
molnova catalog
related products
-
AGPS-IN-2i
AGPS-IN-2i is a potent and high-affinity inhibitor of alkylglycerol phosphate synthase that controls ether lipid utilization and metabolism in cells, reduces ether lipid levels and cell migration, and promotes proliferation and motility of cancer cells.
-
GPLGIAGQ
GPLGIAGQ, a MMP2-cleavable polypeptide, is used as a stimulus-sensitive linker in both liposomal and micellar nanocarriers for MMP2-triggered tumor targeting.
-
Aderamastat
Aderamastat (FP-025) is an orally active matrix metalloproteinase 12 (MMP-12) inhibitor used for research in allergic asthma, COPD, and pulmonary fibrosis.
